ArticlePharmaceuticals (Basel, Switzerland)2026
Aptamers Targeting IL17A and Its Receptor Suppress IL17 Signaling in Different Cell Types.
Anastasiya Solovieva, Dariya Rippinen, Anna Davydova, Veronika Goncharova, Vladimir Koval, Mariya Vorobyeva, Maksim Korolev
Abstract read
In one paragraphArticle in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors.
Anastasiya SolovievaResearch Institute of Clinical and Experimental Lymphology, Affiliated Branch of Federal Research Center of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences, 630117 Novosibirsk, Russia.ORCID 0000-0002-7740-8456 Dariya RippinenResearch Institute of Clinical and Experimental Lymphology, Affiliated Branch of Federal Research Center of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences, 630117 Novosibirsk, Russia.
Anna DavydovaInstitute of Chemical Biology and Fundamental Medicine, Siberian Division of Russian Academy of Sciences, 630090 Novosibirsk, Russia.
Veronika GoncharovaResearch Institute of Clinical and Experimental Lymphology, Affiliated Branch of Federal Research Center of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences, 630117 Novosibirsk, Russia.
Vladimir KovalResearch Institute of Clinical and Experimental Lymphology, Affiliated Branch of Federal Research Center of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences, 630117 Novosibirsk, Russia.ORCID 0009-0009-5363-8909 Mariya VorobyevaInstitute of Chemical Biology and Fundamental Medicine, Siberian Division of Russian Academy of Sciences, 630090 Novosibirsk, Russia.ORCID 0000-0001-5317-3288 Maksim KorolevResearch Institute of Clinical and Experimental Lymphology, Affiliated Branch of Federal Research Center of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences, 630117 Novosibirsk, Russia.
Funding
Ministry of Science and Higher Education of the Russian Federation No. FWNR-2025-0016; № 125012300656-5
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
aptamerfibroblast-like synoviocytesIL-17 receptorinflammationinterleukin-17A (IL-17A)rheumatoid arthritisspondyloarthritis
Identifiers
PMID41754778
PMCPMC12943235
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390